Continuity of prescribers of short-acting beta agonists among children with asthma

Journal of Pediatrics

Volumn 155, Issue 6, 2009, Pages 788-794

  Dombkowski, Kevin J ^a   Harrison, Stephanie Roahen ^a   Cohn, Lisa M ^a   Lewis, Toby C ^b   Clark, Sarah J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; MALE; PATIENT CARE; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ASTHMA; CHILD; CHILD, PRESCHOOL; CONTINUITY OF PATIENT CARE; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICHIGAN; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 73949151557     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.06.033     Document Type: Article

References (55)

1. National Asthma Education and Prevention Program. EPR-3. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH Publication No. 07-4051. Bethesda, MD: U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; 2007.
2. Stempel DA, McLaughlin TP, Stanford RH. Treatment patterns for pediatric asthma prior to and after emergency department events. Pediatr Pulmonol 2005;40:310-5. (Pubitemid 41437608)
3. Lozano P, Finkelstein JA, Hecht J, Shulruff R, Weiss KB. Asthma medication use and disease burden in children in a primary care population. Arch Pediatr Adolesc Med 2003;157:81-8. (Pubitemid 36343423)
4. Halterman JS, Aligne CA, Auinger P, McBride JT, Szilagyi PG. Inadequate therapy for asthma among children in the United States. Pediatrics 2000;105(Pt 3):272-6. (Pubitemid 30033250)
5. Rand CS, Butz AM, Kolodner K, Huss K, Eggleston P, Malveaux F. Emergency department visits by urban African American children with asthma. J Allergy Clin Immunol 2000;105(Pt 1):83-90. (Pubitemid 30059107)
6. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest 1995;108:28-35.
7. Fuhlbrigge A, Carey VJ, Adams RJ, et al. Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care 2004;42:465-71.
8. Shireman TI, Heaton PC, Gay WE, Cluxton RJ, Moomaw CJ. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002;36:557-64. (Pubitemid 34270265)
9. Eisner MD, Lieu TA, Chi F, et al. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Resp J 2001;17: 233-40. (Pubitemid 32600582)
10. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med 2001;155:501-7. (Pubitemid 32280672)
11. Mudd K, Bollinger ME, Hsu VD, Donithan M, Butz A. Pharmacy fill patterns in young urban children with persistent asthma. J Asthma 2006;43: 597-600. (Pubitemid 44581254)
12. Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB. Computer-based models to identify high-risk children with asthma. Am J Resp Crit Care Med 1998;157(Pt 1):1173-80.
13. Naureckas ET, Dukic V, Bao X, Rathouz P. Short-acting beta-agonist prescription fills as a marker for asthma morbidity. Chest 2005;128: 602-8. (Pubitemid 41140486)
14. Speizer FE, Doll R, Heaf P, Strang LB. Investigation into use of drugs preceding death from asthma. Br Med J 1968;1(5588):339-43.
15. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
16. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Resp J 1994;7:1602-9. (Pubitemid 24294244)
17. Anderson HR, Ayres JG, Sturdy PM, et al. Bronchodilator treatment and deaths from asthma: case-control study. BMJ 2005;330(7483):117.
18. Senthilselvan A, Lawson JA, Rennie DC, Dosman JA. Regular use of corticosteroids and low use of short-acting beta-agonists can reduce asthma hospitalization. Chest 2005;127:1242-51. (Pubitemid 46224287)
19. Anis AH, Lynd LD, Wang XH, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001;164:625-31. (Pubitemid 32193861)
20. Farber HJ, Chi FW, Capra A, et al. Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaidinsured children in managed care programs. Ann Allergy Asthma Immunol 2004;92:319-28. (Pubitemid 38380788)
21. Bethell CD, Read D, Brockwood K. Using existing population-based data sets to measure the American Academy of Pediatrics definition of medical home for all children and children with special health care needs. Pediatrics 2004;113(Suppl):1529-37. (Pubitemid 38580674)
22. Homer CJ, Klatka K, Romm D, et al. A review of the evidence for the medical home for children with special health care needs. Pediatrics 2008;122:e922-37.
23. Turchi RM, Gatto M, Antonelli R. Children and youth with special healthcare needs: there is no place like (a medical) home. Curr Opin Pediatr 2007;19:503-8. (Pubitemid 47075634)
24. Toomey SL, Finkelstein J, Kuhlthau K. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics 2008;122:368-74.
25. Leone FT, Grana JR, McDermott P, MacPherson S, Hanchak NA, Fish JE. Pharmaceutically-based severity stratification of an asthmatic population. Respir Med 1999;93:788-93.
26. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91. (Pubitemid 27123948)
27. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest 2005; 128:1968-73. (Pubitemid 41507529)
28. Leidy NK, Paramore LC, Watrous M, Doyle J, Zeiger RS. Development of an algorithm for estimating asthma severity from an administrative cost database [abstract]. Value Health 1999;2:394.
29. Allen-Ramey FC, Bukstein D, Luskin A, Sajjan SG, Markson LE. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. J Managed Care Pharm 2006; 12:310-21. (Pubitemid 47394446)
30. Diette GB, Wu AW, Skinner EA, et al. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled betaagonists and underuse of inhaled corticosteroids. Arch Intern Med 1999;159:2697-704.
31. Schatz M, Zeiger RS, Vollmer WM, et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006;117:995-1000.
32. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-11. (Pubitemid 32268455)
33. Use of appropriate medications for people with asthma (ASM) - denominator. http://www.ncqa.org/tabid/210/Default.aspx. Accessed June 8,2008.
34. Dombkowski KJ, Wasilevich EA, Lyon-Callo SK. Pediatric asthma surveillance using Medicaid claims. Public Health Rep 2005;120: 515-24. (Pubitemid 41353759)
35. Fuhlbrigge AL, Carey VJ, Finkelstein JA, et al. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization. Am J Managed Care 2005;11:325-30. (Pubitemid 40646937)
36. Mosen DM, Macy E, Schatz M, et al. How well do the HEDIS asthma inclusion criteria identify persistent asthma? Am J Managed Care 2005;11:650-4. (Pubitemid 41527685)
37. Cabana MD, Slish KK, Nan B, Clark NM. Limits of the HEDIS criteria in determining asthma severity for children. Pediatrics 2004;114:1049-55. (Pubitemid 41529772)
38. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
39. Zeger SL, Liang K- Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
40. Berger WE, Legorreta AP, Blaiss MS, et al. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004;93: 538-45. (Pubitemid 39628275)
41. Donahue JG, Fuhlbrigge AL, Finkelstein JA, et al. Asthma pharmacotherapy and utilization by children in 3 managed care organizations. The Pediatric Asthma Care Patient Outcomes Research Team. J Allergy Clin Immunol 2000;106:1108-14. (Pubitemid 32006265)
42. Schatz M, Nakahiro R, Jones CH, Roth RM, Joshua A, Petitti D. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Managed Care 2004;10:25-32. (Pubitemid 38165570)
43. Cabana MD, Bruckman D, Bratton SL, Kemper AR, Clark NM. Association between outpatient follow-up and pediatric emergency department asthma visits. J Asthma 2003;40:741-9. (Pubitemid 37377411)
44. Camargo CA Jr., Ramachandran S, Ryskina KL, Lewis BE, Legorreta AP. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health-System Pharm 2007;64:1054-61. (Pubitemid 46801537)
45. Cyr M-C, Martens AC, Berbiche D, Perreault S, Blais L. Continuity of care in the ambulatory treatment of adolescents with asthma. J Adolescent Health 2006;39:926. e911-7.
46. Shields AE, Finkelstein JA, Comstock C, Weiss KB. Process of care for Medicaid-enrolled children with asthma: served by community health centers and other providers. Med Care 2002;40:303-14.
47. Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. [see comment]. Thorax 1996;51:1093-9. (Pubitemid 26402820)
48. Abramson MJ, Bailey MJ, Couper FJ, et al. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med 2001;163:12-8. (Pubitemid 32095246)
49. Cree M, Bell NR, Johnson D, Carriere KC. Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma. Dis Manage 2006;9:63-71.
50. Turk A. Using the HEDIS asthma measurement. Am J Managed Care 2000;6:S347-54.
51. National Asthma Education and Prevention Program. Guidelines implementation panel report for: Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH Publication No. 09-6147.Bethesda, MD: U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; December 2008.
52. Christakis DA, Mell L, Koepsell TD, Zimmerman FJ, Connell FA. Association of lower continuity of care with greater risk of emergency department use and hospitalization in children. Pediatrics 2001;107:524-9. (Pubitemid 32183187)
53. Pediatrics AAo. Policy statement. The medical home. Pediatrics 2002; 110:184-6.
54. Mainous AG, Gill JM. The importance of continuity of care in the likelihood of future hospitalization: is site of care equivalent to a primary clinician? Am J Public Health 1998;88:1539-41. (Pubitemid 28455765)
55. Xu KT. Usual source of care in preventive service use: a regular doctor versus a regular site. Health Services Res 2002;37:1509-29. (Pubitemid 36070252)